DUBLIN (AP) — DUBLIN (AP) — Jazz Pharmaceuticals PLC (JAZZ) on Wednesday reported third-quarter profit of $251.4 million.
On a per-share basis, the Dublin-based company said it had profit of $4.08. Earnings, adjusted for one-time gains and costs, came to $8.13 per share.
The results surpassed Wall Street expectations. The average estimate of 10 analysts surveyed by Zacks Investment Research was for earnings of $5.74 per share.
The drugmaker posted revenue of $1.13 billion in the period, which also beat Street forecasts. Nine analysts surveyed by Zacks expected $1.1 billion.
Jazz expects full-year earnings in the range of $7.65 to $8.45 per share, with revenue in the range of $4.18 billion to $4.28 billion.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on JAZZ at https://www.zacks.com/ap/JAZZ
Copyright © 2025 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.
